China Resources Jiangzhong's Jianwei Xiaoshi Tablets Obtain Macau Chinese Patent Medicine Registration Certificate

Jiemian··MOCN·Read original
1▲1 ▼0Impact / 5
Summary · why it matters

China Resources Jiangzhong announced that the company recently received the Chinese Patent Medicine Registration Certificate for Jianwei Xiaoshi Tablets, Jiangzhong brand, approved and issued by the Pharmaceutical Administration Bureau of the Macau Special Administrative Region Government. The dosage form is tablets, and the category is over-the-counter Chinese patent medicine. The product's functions and indications are to strengthen the stomach and promote digestion, used for food stagnation and indigestion caused by weakness of the spleen and stomach. The company stated that after obtaining this certificate, the product can be sold in Macau, which is conducive to expanding overseas market business and enhancing brand influence and market competitiveness. However, the company also pointed out that its internationalization business is still in the exploratory stage and is not expected to have a material impact on recent operating performance. Drug sales are subject to uncertainties due to factors such as the market environment and industry policies.

Impact on assets 1

Others▲
Jiangzhong Pharmaceutical Co Ltd
600750
▲ PositiveRegulationrelevance

Obtained Macau Chinese Patent Medicine Registration Certificate for Jianwei Xiaoshi Tablets, allowing sales in Macau and expanding overseas market business.